Stay updated on Safety of SAGE-718 in Huntington's Disease Clinical Trial

Sign up to get notified when there's something new on the Safety of SAGE-718 in Huntington's Disease Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Safety of SAGE-718 in Huntington's Disease Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    2 days ago
    No Change Detected
  3. Check
    3 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.8.0 to v2.8.1, indicating a recent revision in the content of the webpage.
    Difference
    0.1%
    Check dated 2024-06-13T20:15:48.000Z thumbnail image
  4. Check
    4 days ago
    No Change Detected
  5. Check
    5 days ago
    No Change Detected
  6. Check
    10 days ago
    Change Detected
    Summary
    The value on the webpage has changed from 7 to 8, indicating a recent update in the study details related to the safety and tolerability evaluation of SAGE-718 in participants with Huntington's Disease.
    Difference
    0.1%
    Check dated 2024-06-06T14:19:23.000Z thumbnail image
  7. Check
    25 days ago
    Change Detected
    Summary
    The 'Participation Criteria' section has been updated to include detailed eligibility criteria for participants, specifying requirements such as completion of previous studies, age range, and health conditions, as well as exclusion criteria for certain medical conditions and treatments.
    Difference
    29%
    Check dated 2024-05-22T20:31:04.000Z thumbnail image
  8. Check
    46 days ago
    Change Detected
    Difference
    1%
    Check dated 2024-04-30T22:28:54.000Z thumbnail image

Stay in the know with updates to Safety of SAGE-718 in Huntington's Disease Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Safety of SAGE-718 in Huntington's Disease Clinical Trial page.